Blog

There’s a common misconception that only GLP-compliant Contract Research Organisations (CROs) can meaningfully support clinical development. In reality, many pharma and biotech teams rely on non-GLP laboratories for a wide...

The preclinical drug testing landscape is undergoing a profound transformation. For decades, drug development has depended heavily on animal models and simple two-dimensional (2D) cell cultures to evaluate the safety...

Advancing COPD research with a physiologically relevant ALI model It’s World COPD Day 2025, a day created to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and its symptoms. At...

October is Breast Cancer Awareness Month, a month dedicated to raising awareness for breast cancer, spotting early signs and the research being done in the hopes of finding a cure.  ...

Oscar Neil is one of the younger and more recent additions to Cellomatics, having joined the CRO in August 2023, after completing an undergraduate degree in Pharmacology at the University...

What role do contract research organisations have to play in pre-clinical trials? UK-based Contract Research Organisations (CROs) are increasingly stepping onto the global stage, positioning themselves as vital partners in...

Each year, approximately 40,000 people in the UK receive a new blood cancer diagnosis [1]. In other words: someone in the UK receives a blood cancer diagnosis every 14 minutes....

August is Psoriasis Awareness Month, a time used to raise awareness about psoriasis, a chronic autoimmune condition affecting the skin. The month is dedicated to educating the public, supporting those...

In this blog Senior Bioassay Scientist Tsemay Tse and Bioassay Study Manager Alex Timmis discuss the latest innovations in skin research, the rise in in vitro alternatives and how the...